OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
191
Results
Show all
Save search
Copy query
Show results for
Unknown
(176)
Genomics
(10)
Proteomics
(3)
Transcriptomics
(1)
Clinical
(1)
Organisms
Alphavirus
(2)
Archaea
(2)
Bacteria
(2)
Betaherpesvirinae
(2)
Borrelia
(2)
Botrytis cinerea
(2)
Chlorella vulgaris
(2)
Clostridium perfringens
(2)
Eukaryota
(2)
Fungi
(2)
Hepatitis B virus
(2)
Human betaherpesvirus 5
(2)
Influenza A virus
(2)
Influenza C virus
(2)
Japanese encephalitis virus group
(2)
Mammarenavirus
(2)
Miscanthus x giganteus
(2)
Mycobacterium tuberculosis
(2)
Orthoflavivirus
(2)
Panicum virgatum
(2)
Pseudomonas aeruginosa
(2)
Rattus
(2)
Saccharomyces cerevisiae
(2)
Schizosaccharomyces
(2)
Schizosaccharomyces pombe
(2)
Severe acute respiratory syndrome coronavirus 2
(2)
Staphylococcus aureus
(2)
Streptococcus pneumoniae
(2)
Strongyloides ratti
(1)
Homo sapiens
(1)
Organisms
Strongyloides ratti
(2)
Strongyloides nasua
(1)
human gut metagenome
(1)
Repository
ENA
(10)
pride
(2)
biostudies-arrayexpress
(1)
jPOST
(1)
Tissue
Blood serum
(1)
Feces
(1)
Disease
0 Intestinal strongyloidiasis
(1)
Technology Type
Mass Spectrometry
(2)
Shotgun proteomics
(2)
SWATH MS
(1)
Instrument Platform
Illumina Genome Analyzer II
(1)
Publication Date
2024
(2)
2013
(1)
2023
(1)
First Public Date
2026
(2)
2022
(2)
2013
(2)
2017
(1)
2014
(1)
2012
(1)
2011
(1)
Classification
helminths
(3)
Study status
Completed
(1)
Study type
RNA-seq of coding RNA
(1)
Observational
(1)
Release Date
2023
(24)
2024
(20)
2025
(19)
2022
(18)
2018
(17)
2020
(14)
2021
(13)
2019
(13)
2017
(7)
2014
(7)
2015
(6)
2016
(5)
2013
(3)
2011
(3)
2026
(2)
2012
(2)
2010
(1)
2009
(1)
2008
(1)
2004
(1)
Lab affiliation
Biological Mass Spectrometry Lab Department of Translational Medicine (DiMeT) Center for Translational Research on Autoimmune & Allergic Diseases - CAAD University of Piemonte Orientale Novara, Italy
(1)
Biological Mass Spectrometry Lab, Department of Translational Medicine (DiMeT), Center for Translational Research on Autoimmune & Allergic Diseases - CAAD University of Piemonte Orientale, Novara, Italy
(1)
Location
Peru
(1)
United States
(1)
Tags
pathogen:helminth
(3)
pathogen
(3)
xref:ArrayExpress:E-ERAD-92
(1)
xref:PubMed:42237397
(1)
Previous
page
1 / 20
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
20
Next
page
Sort
by:
Relevance
Page size
10
Surveillance of strongyloidiasis in Spanish in-patients (1998-2014).
Not available
S-EPMC5746217
|
biostudies-literature
Cite
Strongyloidiasis and Culture-Negative Suppurative Meningitis, Japan, 1993-2015.
Not available
S-EPMC6256405
|
biostudies-literature
Cite
A bibliometric analysis of human strongyloidiasis research (1968 to 2017).
Not available
S-EPMC6921599
|
biostudies-literature
Cite
Bacteriophage-fused peptides for serodiagnosis of human strongyloidiasis.
Not available
S-EPMC4038474
|
biostudies-literature
Cite
Pulmonary Strongyloidiasis Masquerading as Exacerbation of Chronic Obstructive Pulmonary Disease.
Not available
S-EPMC5077736
|
biostudies-literature
Cite
Strongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian indigenous communities.
Not available
S-EPMC4177786
|
biostudies-literature
Cite
Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis.
Not available
S-EPMC6037348
|
biostudies-literature
Cite
Feline strongyloidiasis: An insight into its global prevalence and transmission cycle.
Not available
S-EPMC11255105
|
biostudies-literature
Cite
Serological diagnosis of strongyloidiasis: An evaluation of three commercial assays.
Not available
S-EPMC11253981
|
biostudies-literature
Cite
Clinical Characteristics of Strongyloidiasis during the COVID-19 Pandemic: Systematic Scoping Review.
Not available
S-EPMC10160902
|
biostudies-literature
Cite
Previous
page
1 / 20
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
20
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
